AbbVie Inc. — Director's Dealing 2017

Feb 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2017-02-02

Reporting Person: SALEKI-GERHARDT AZITA (SVP, Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-02	Common stock, $0.01 par value	M	2400	$27.29	Acquired	5431	Indirect
2017-02-02	Common stock, $0.01 par value	F	1558	$60.89	Disposed	3873	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-02	Option (right to buy)	$27.29	M	2400	Disposed	2017-02-15	Common stock (2400)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, $0.01 par value	84579	Direct
Common stock, $0.01 par value	1863	Indirect

Footnotes

F1: Balance in the AbbVie Savings Program as of February 2, 2017.

F2: The reporting person disclaims beneficial ownership of all securities held by her spouse.